South Africa Anti-Infective Market Key Players and Opportunities by 2027

South Africa Anti-Infective Market to 2027 - Regional Analysis and Forecasts by Type (Antibacterial, Antiviral and Antifungal); Range (Broad Spectrum and Narrow Spectrum), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Mail Order Pharmacies)

Historic Data: 2016-2017 | Base Year: 2018 | Forecast Period: 2019-2027
  • Status : Published
  • Report Code : TIPRE00006585
  • Category : Life Sciences
  • No. of Pages : 68
  • Available Report Formats : pdf-format excel-format
  • Last update date : February 15, 2025
South Africa Anti-Infective Market Key Players and Opportunities by 2027
Report Date: February 15, 2025   |   Report Code: TIPRE00006585 Email: sales@theinsightpartners.com

2018 Market Size

US$ 1,893.5 Mn

Base year value

2027 Forecast

US$ 2,572.5 Mn

Projected by 2027

CAGR 2019-2027

3.6 %

Growth rate

Addressable Market

US$ 20,422.83 Mn

(2019-2027)

The South Africa anti-infective market is expected to reach US$ 2,572.5 Mn in 2027 from US$ 1,893.5 Mn in 2018. The market is estimated to grow with a CAGR of 3.6% from 2019-2027.

The growth of the market is driven by the factors such as,rise in the cases of viral diseases in South Africa. However, the market is likely to get impacted due to lack of awareness regarding fungal infections in South Africa.

In South Africa, almost 7.52 million people were living with HIV in 2018, as per data released by GHE. Also, during the year 2017, approximately 21% of South Africa patients living with HIV were from South Africa. The projected overall HIV prevalence rate during 2018 was almost 13.1% among the South African population, whereas for adults between 15-49 years, an estimated 19.0% of the population is found to be HIV positive. Also, South Africa has one of the highest rates of liver cancer in the world, which is related to the increased rate of HBV among adults.

Also, the incidences of tinea capitis are dominating in South Africa. Also, the country has a more significant number of tuberculosis and HIV, which further leads to a considerable amount of cases for chronic pulmonary aspergillosis (CPA). Moreover, as the data published at Gulf Conference on Clinical Microbiology and Infectious Diseases stated that approximately 99,350 cases of CPA were present in South Africa. The prevalence rate was nearly 175/100,000, which is the highest prevalence in the world. Furthermore, as per the data published by the CDC in April 2019 stated that in 2012-2016, Candida auris affected nearly 451 patients across the country. Therefore, owing to increasing prevalence across the country are likely to drive the growth of the anti-infective market during the forecast period.

South Africa anti-infective market, based on distribution channel was segmented into hospital pharmacies, retail pharmacies, and online pharmacies. In 2018, the hospital pharmacies segment held the largest share of the market, by distribution channel. This segment is also anticipated to grow at the highest rate during the forecast period.

South Africa Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

TIPRE00006585-img1
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.


ASIA PACIFIC DIABETES CARE DEVICES – MARKET SEGMENTATION


By Type

  • Antibacterial
  • Antiviral
  • Antifungal


By Application

  • Broad Spectrum
  • Narrow Spectrum


By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online pharmacies


Company Profiles

  • Sanofi
  • Abbott
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Bayer AG
  • Johnson & Johnson Services, Inc.
  • Sandoz International GmbH
  • Aspen Holdings
  • Astellas Pharma Inc.

South Africa Anti-Infective Report Scope

Report Attribute Details
Market size in 2018 US$ 1,893.5 Million
Market Size by 2027 US$ 2,572.5 Million
CAGR (2019 - 2027) 3.6%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By Type
  • Antibacterial
  • Antiviral and Antifungal
By Range
  • Broad Spectrum and Narrow Spectrum
By and Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies and Mail Order Pharmacies
Regions and Countries Covered South Africa
  • South Africa
Market leaders and key company profiles
  • Sanofi
  • Abbott
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Bayer AG
  • Johnson & Johnson Services, Inc.
  • Sandoz International GmbH
  • Aspen Holdings
  • Astellas Pharma Inc.
Trupti Wadekar
Assistant Manager,
Market Research & Consulting

Trupti is a senior consultant with over 10 years of experience in the Healthcare sector, specializing in pharmaceuticals, biotechnology, and life-sciences markets. She holds a Bachelor’s degree in Biotechnology and an MBA with dual specialization in Marketing and Pharmaceuticals & Biotechnology, combining a strong scientific foundation with a strategic and commercial perspective. Her professional experience encompasses market research, competitive intelligence, strategic advisory, and business development, supporting clients across diverse and evolving healthcare markets.

She has worked extensively on market sizing and assessment, growth strategy, market expansion, and strategic decision-making initiatives, helping clients identify opportunities and address complex business challenges. Trupti brings strong expertise in client engagement, stakeholder management, team leadership, and translating research findings into actionable business insights. Her ability to connect scientific understanding with market dynamics and commercial strategy enables her to deliver practical, high-impact solutions aligned with client objectives.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA